资讯

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
FDA announces plans to restrict access for COVID vaccines
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications
US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...
FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
FDA approves Novavax COVID vaccine with new conditions
President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House ...
Food and Drug Administration lays out new requirements for annual COVID-19 vaccines
Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
FDA expands COVID vaccine warning about possible side effect
The Food and Drug Administration is telling Pfizer and Moderna to expand the warning labels on their COVID-19 vaccines about ...
Axios on MSN23 分钟
FDA expands warnings of heart risks on COVID shots
The Food and Drug Administration is requiring Pfizer and Moderna to expand warnings on the labels of their COVID-19 vaccines ...
InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...